First-Trimester Triglyceride-Glucose Index and Triglyceride/High-Density Lipoprotein Cholesterol are Predictors of Gestational Diabetes Mellitus Among the Four Surrogate Biomarkers of Insulin Resistance
Ning Ma,Liwei Bai,Qiang Lu
DOI: https://doi.org/10.2147/dmso.s454826
2024-04-09
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Ning Ma, 1 Liwei Bai, 2 Qiang Lu 1 1 Department of Endocrinology, First Hospital of Qinhuangdao, Hebei, Qinhuangdao, 066000, People's Republic of China; 2 Qinhuangdao Hospital for Maternal and Child Health, Hebei, Qinhuangdao, 066000, People's Republic of China Correspondence: Qiang Lu, Department of Endocrinology, First Hospital of Qinhuangdao, Hebei, Qinhuangdao, 066000, People's Republic of China, Tel +86 13933909066, Email Purpose: This study seeks to assess the potential of early pregnancy Triglyceride Glucose Index (TyG), triglyceride to High-Density Lipoprotein Cholesterol ratio (TG/HDL-c), Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol ratio (LDL-C/HDL-C), and Total Cholesterol to High-Density Lipoprotein Cholesterol ratio (TC/HDL-C) in predicting Gestational Diabetes Mellitus (GDM). Patients and Methods: A total of 1073 adults singleton pregnant women were enrolled from June 2017 to September 2019. Complete anthropometric data and lipid profiles were measured in the first trimester (before 12 weeks gestation) and a 75g oral glucose tolerance test (OGTT) at 24– 28 weeks was performed. Based on OGTT results, participants were categorised into Normal Glucose Tolerance (NGT) group (n=872) and GDM group (n=201). General data, laboratory test results, and surrogate insulin resistance indicators such as TyG index, TG/HDL-C, LDL-C/HDL-C, and TC/HDL-C were documented and compared. To compare differences between the two groups, t- test was used, Spearman correlation analysis and linear regression analysis were performed to establish associations between these indicators and insulin resistance in GDM. Receiver Operating Characteristic (ROC) curves were generated to compare the thresholds of these indicators for predicting GDM during pregnancy and to quantify overall diagnostic accuracy. Results: Individuals with GDM had higher TyG, TG/HDL-C, and LDL-C/HDL-C levels ( P < 0.001), but with no significant difference observed in TC/HDL-C. All four ratios were positively correlated with Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), yet only TyG emerged as an independent risk factor for HOMA-IR. The Area under the Curve (AUC) of TyG index (0.692) was comparable to that of HOMA-IR (0.703). The cut-off points for TyG index, TG/HDL-C, and HOMA-IR in predicting GDM were 7.088, 0.831, and 1.8, respectively. HOMA-IR exhibited the highest sensitivity (79.1%), while TyG index (64.3%) and TG/HDL-C ratio (64.3%) demonstrated better specificity compared to HOMA-IR (56.3%). LDL-C/HDL-C and TC/HDL-C offered no discernible predictive advantage. Conclusion: Early pregnancy TyG index and TG/HDL-C can aid in identifying pregnant women at risk for GDM, potentially facilitating early and effective intervention to improve prognosis. TyG index exhibited superior predictive capability compared to TG/HDL-C. Keywords: TyG, gestational diabetes mellitus, glucose and lipid metabolism, insulin resistance Gestational Diabetes Mellitus (GDM) stands as a prevalent comorbidity during pregnancy, exerting short- and long-term adverse effects on mother and infant, large-for-gestational-age (LGA) infants were particularly common. 1,2 Emma Assi et al used a proteomic approach to find that placental dysfunction may be directly responsible for abnormal growth and development of GDM fetuses. 3 GDM and T2DM share both non-genetic and genetic risk factors, including obesity, poor diet and sedentary lifestyle; MTNR1B, TCF7L2, CDKAL1 and CDKN2A-CDKN2B of the GDM loci have been reported at genome-wide significance for T2DM. 4 The etiology of GDM remains elusive, with insulin resistance and islet beta cell dysfunction recognised as pivotal pathophysiological foundations. Established risk factors for GDM include increasing body mass index (BMI), advanced maternal age and increases in insulin resistance (IR). 5 The homeostasis model assessment for insulin resistance (HOMA-IR) index is the most widely used to evaluate the degree of IR. 6 However, it is not readily available in the early stages, and insulin testing is expensive. So it is a good idea to use routine antenatal testing indicators instead of IR to predict the risk of GDM. Past investigations have identified metabolic indicators, such as the Triglyceride/Glucose Index (TyG) and Triglyceride/High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C), as reliable markers for discerning high-risk groups prone to insulin resistance and metabolic disorders in non-pregnant individuals. 7–9 Nonetheless, evidence linking these indicators to insulin resistance (IR) and GDM in pregnant individuals remains scarce. Thus, the query persists: do these straightforwa -Abstract Truncated-
endocrinology & metabolism